A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)

Name: A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)
Published: 2021
License: Public Domain

AstraZeneca · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

anemia chronic-kidney-disease

anemia of chronic kidney disease, recombinant human erythropoietin, roxadustat, coronavirus disease of 2019, chronic kidney disease, anemia, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Investigate the Effect of Roxadustat Versus Recombinant Human Erythropoietin (rHuEPO) on Oral Iron Absorption in Chinese Patients With Anemia of Chronic Kidney Disease (CKD)

Related documents